Not applicableUnknownNCT05133388What this trial is testingThe Prevelence of HBB c.93-21 G-A in β Thalassemia PatientsWho this might be right forBeta-Thalassemia Assiut University 150
Not applicableStudy completedNCT00159029What this trial is testingGenetics of Alpha Thalassemia in Israeli Ethnic GroupsWho this might be right forAlpha Thalassemia Deborah Rund 100
Not applicableActive Not RecruitingNCT05145062What this trial is testingLong - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.Who this might be right forBlood and Lymphatic Diseases Sangamo Therapeutics 8
Large-scale testing (Phase 3)Study completedNCT01181154What this trial is testingRituximab in Auto-Immune Hemolytic AnemiaWho this might be right forWarm Autoimmune Hemolytic Anemia Assistance Publique - Hôpitaux de Paris 32
Not applicableUnknownNCT05564845What this trial is testingBrain Structure and Neurocognitive Development in Sickle Cell Disease; a Longitudinal Cohort Study (BRICK Study)Who this might be right forBrain Development AbnormalitySickle Cell Disease Dr. Marjon H. Cnossen MD PhD 84
Not applicableLooking for participantsNCT05805202What this trial is testingFunctional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized TherapyWho this might be right forAtypical Hemolytic Uremic Syndrome Mario Negri Institute for Pharmacological Research 112
Testing effectiveness (Phase 2)Study completedNCT01703104What this trial is testingThe Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell AnemiaWho this might be right forSickle Cell Anemia Lagos State University 150
Not applicableStudy completedNCT03293641What this trial is testingZinc Supplementation in Children With Sickle Cell Disease in Western KenyaWho this might be right forSickle Cell DiseaseZinc DeficiencyInfection Lucas Otieno Tina, MD MSc 40
Testing effectiveness (Phase 2)Ended earlyNCT02389231What this trial is testingEvaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional TreatmentWho this might be right forAutoimmune Hemolytic Anemia University Hospital, Bordeaux 2
Not applicableStudy completedNCT00874172What this trial is testingEffectiveness of New Analgesic Strategy Compared to the Usal Antalgic StrategyWho this might be right forSickle Cell Anemia Assistance Publique - Hôpitaux de Paris 176
Post-approval studies (Phase 4)Study completedNCT00707850What this trial is testingPegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus InfectionWho this might be right forHepatitis CThalassemia Baqiyatallah Medical Sciences University 300
Not applicableUnknownNCT06058117What this trial is testingPaediatric European Group A Streptococcal United Study.Who this might be right forInvasive Group A Beta-Haemolytic Streptococcal Disease Noordwest Ziekenhuisgroep 500
Not applicableStudy completedNCT00005467What this trial is testingIndices of Severity and Prognosis for Sickle Cell DiseaseWho this might be right forAnemia, Sickle CellBlood Disease National Heart, Lung, and Blood Institute (NHLBI)
Not applicableEnded earlyNCT02636387What this trial is testingDesmopressin as a Therapy for Bedwetting in Children With Sickle Cell DiseaseWho this might be right forNocturnal EnuresisAnemia, Sickle Cell Montefiore Medical Center 14
Not applicableAvailableNCT06731036What this trial is testingExpanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell BoostsWho this might be right forSevere Combined ImmunodeficiencyFanconi AnemiaDyskeratosis Congenita+1 more University of Florida
Not applicableLooking for participantsNCT06923111What this trial is testingPASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]Who this might be right forSickle Cell Disease Nova Laboratories Limited 180
Large-scale testing (Phase 3)Looking for participantsNCT06932471What this trial is testingStudy of Safety and Efficacy of MY008211A in Patients With Residual Anemia Despite Anti-C5 Antibody TreatmentWho this might be right forParoxysmal Nocturnal Hemoglobinuria Wuhan Createrna Science and Technology Co., Ltd 20
Testing effectiveness (Phase 2)Ended earlyNCT05086744What this trial is testingBasket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological DisordersWho this might be right forImmune Thrombocytopenia (ITP)Cold Agglutinin Disease (CAD) Novartis Pharmaceuticals 19
Not applicableNot Yet RecruitingNCT07502781What this trial is testingHeterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm InfantsWho this might be right forExtremely Premature InfantAnemia NeonatalBlood Transfusion+6 more Hospital Clinic of Barcelona 176
Not applicableActive Not RecruitingNCT02692872What this trial is testingScreening for Alpha Thalassemia in Healthy VolunteersWho this might be right forAlpha Thalassemia National Institute of Allergy and Infectious Diseases (NIAID) 367